Pulmonary Safety of Repeat Doses of Staccato Loxapine for Inhalation in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2009
At a glance
- Drugs Loxapine (Primary)
- Indications Migraine; Schizophrenia
- Focus Adverse reactions
- Sponsors Alexza Pharmaceuticals
- 06 May 2009 Actual end date added as 1 Apr 2009.
- 06 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Nov 2008 New trial record.